Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

NCT01870908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 664

Last updated 2015-10-05

No results posted yet for this study

Summary

This study is to evaluate the safety and the effectiveness of treatment with tacrolimus and biological agents.

Conditions

Interventions

DRUG

tacrolimus

DRUG

biological agents

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870908 on ClinicalTrials.gov